Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Rolling out the radical cure for vivax malaria in Asia: a qualitative study among policy makers and stakeholders.

Adhikari B. et al, (2021), Malaria journal, 20

Protective effect of Mediterranean-type glucose-6-phosphate dehydrogenase deficiency against Plasmodium vivax malaria

Awab GR. et al, (2021), eLife, 10

Polymorphisms in Plasmodium vivax antifolate resistance markers in Afghanistan between 2007 and 2017.

Rakmark K. et al, (2020), Malaria journal, 19

COVID-19 and risks to the supply and quality of tests, drugs, and vaccines

Newton PN. et al, (2020), The Lancet Global Health, 8, e754 - e755

Competing risk events in antimalarial drug trials in uncomplicated Plasmodium falciparum malaria: a WorldWide Antimalarial Resistance Network individual participant data meta-analysis

(2019), Malaria Journal, 18

Provider and household costs of Plasmodium vivax malaria episodes: a multicountry comparative analysis of primary trial data

Devine A. et al, (2019), Bulletin of the World Health Organization, 97, 828 - 836

The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis

Commons RJ. et al, (2019), BMC Medicine, 17

The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysis

Commons RJ. et al, (2019), PLOS Medicine, 16, e1002928 - e1002928

Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial

Taylor WRJ. et al, (2019), The Lancet, 394, 929 - 938

The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis

Commons RJ. et al, (2018), The Lancet Infectious Diseases, 18, 1025 - 1034

Chloroquine–Primaquine versus Chloroquine Alone to Treat Vivax Malaria in Afghanistan: An Open Randomized Superiority Trial

Awab GR. et al, (2017), The American Journal of Tropical Medicine and Hygiene, 97, 1782 - 1787

Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introduction

Awab GR. et al, (2016), Malaria Journal, 15

Gametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient data

(2016), BMC Medicine, 14

A Worldwide Map ofPlasmodium falciparumK13-Propeller Polymorphisms

Ménard D. et al, (2016), New England Journal of Medicine, 374, 2453 - 2464

Improving the radical cure of vivax malaria (IMPROV): a study protocol for a multicentre randomised, placebo-controlled comparison of short and long course primaquine regimens

(2015), BMC Infectious Diseases, 15

A Population Survey of the Glucose-6-Phosphate Dehydrogenase (G6PD) 563C>T (Mediterranean) Mutation in Afghanistan

Jamornthanyawat N. et al, (2014), PLoS ONE, 9, e88605 - e88605

The Effect of Dosing Regimens on the Antimalarial Efficacy of Dihydroartemisinin-Piperaquine: A Pooled Analysis of Individual Patient Data

(2013), PLoS Medicine, 10, e1001564 - e1001564

Prevalence of antifolate resistance mutations in Plasmodium falciparum isolates in Afghanistan

Awab GR. et al, (2013), Malaria Journal, 12

Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial

Awab GR. et al, (2010), Malaria Journal, 9

Include forthcoming?